Research Article

Effect of Nigella Sativa Oil on Oxidative Stress, Inflammatory, and Glycemic Control Indices in Diabetic Hemodialysis Patients: A Randomized Double-Blind, Controlled Trial

Table 2

Serum concentrations of oxidative stress markers, hs-CRP, and glycemic indices of the patients.

VariablesNigella sativa group (N = 20)Placebo group (N = 21)MDP

SOD (U/mL)
Baseline185.60 (4.50)192.69 (4.75)−7.09.287b
End203.48 (3.24)198.03 (4.48)5.44.064c, .040d
MD (95% CI)−17.88 (−26.87, −8.89)-5.34 (-13.03, 2.33)
Pa.001.162
TAC (mmol/L)
Baseline1.34 (.01)1.36 (.01)−.01.331b
End1.40 (.01)1.35 (.01).05<.001c, <.001d
MD (95% CI)−.06 (−.08, −.04).01 (−.01, .03)
Pa<.001.353
MDA (μmol/L)
Baseline2.19 (.07)1.91 (.06).27.007b
End1.86 (.05)1.89 (.05)−.02.022c, .025d
MD (95% CI).32 (.23, .42).01 (-.11, .15)
Pa<.001.782
Hs-CRP (mg/L)
Baseline8.59 (.40)9.01 (.59)−42.560b
End7.55 (.38)8.86 (.57)−1.30.022c, .017d
MD (95% CI)1.04 (.63, 1.44).15 (-.62, .93)
Pa<.001.680
FBS (mg/dL)
Baseline190.70 (6.08)156.57 (3.43)3.24.510b
End149.91 (2.68)152.85 (3.10)−2.93.004c, .027d
MD (95% CI)−16.38 (−25.04, −7.72)−1.99 (−13.68, 9.70)
Pa.001.726
INS (μIU/mL)
Baseline15.91 (2.07)19.39 (2.49)-3.47.294b
End19.66 (1.98)20.00 (2.28)-.34.459c, .558d
MD (95% CI)3.74 (1.10, 6,38).60 (−4.13, 5.35)
Pa.008.791
HbA1c (%)
Baseline8.26 (.33)8.38 (.37)−11.815b
End7.76 (.23)8.32 (.31)−55.009c, .014d
MD (95% CI)−.49(−90, −09)−.06 (−.29, .17)
Pa.019.572

Mean (SD) and mean differences (95% CI) are presented for normally distrusted data; median (IQB) and median differences are presented for data not normally distributed. SOD = superoxide dismutase; MDA = malondialdehyde; TAC = total antioxidant capacity; hs-CRP = high-sensitivity C-reactive protein; FBS = fasting blood sugar; INS = insulin; MD = mean difference; SD = standard deviation; IQR = interquartile range; ANCOVA = analysis of covariance. Pa = paired samples t-test, Pb = independent samples t-test, Pc = ANCOVA test, adjusted for baseline values (Model 1), and Pd = ANCOVA test, adjusted for baseline values, energy intake1, and BMI (Model 2).